Company Changsheng Bio-technology Co Ltd

002680

CNE100001DY7

Pharmaceuticals

Business Summary

Managers

Members of the board

Share class

Company contact information

Sector

Sector Biopharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets
- ^CNY	-

2018	Changsheng Bio technology : China issues new delisting rules, to delist vaccine maker Changsheng	RE
2018	Hengli Indstrl Development : China's U-turn on market curbs brings back the speculators	RE

Changsheng Bio-technology Co., Ltd., formerly Lianyungang Huanghai Machinery Co., Ltd., is a China-based company principally engaged in the research, development, production and sale of human vaccine products. The Company's main products include live attenuated freeze-dried varicella vaccine, freeze-dried human rabies vaccine (Vero cells), freeze-dried live attenuated hepatitis A vaccine, influenza lysis vaccine, adsorption of cell-free diphtheria combined vaccine and ACYW Group 135 meningococcal polysaccharide vaccine. The Company distributes its products in domestic market and to overseas markets.

Managers	Title	Age	Since
Hong Quan Lu CEO	Chief Executive Officer	45	21-05-20
Chi Wu Chen CTO	Chief Tech/Sci/R&D Officer	59	08-12-31
Xiang Ming Wang BRD	Director/Board Member	52	93-12-31
Wei Gui IRC	Investor Relations Contact	39	-

Members of the board	Title	Age	Since
Ji Ti Liu BRD	Director/Board Member	68	09-12-31
Xiang Ming Wang BRD	Director/Board Member	52	93-12-31
Hong Quan Lu CEO	Chief Executive Officer	45	21-05-20
Tie Cheng Lu BRD	Director/Board Member	-	21-08-05
Guo Xue Zhao BRD	Director/Board Member	-	21-08-05

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	973,690,378	304,425,143 ( 31.27 %)	0	31.27 %

Changsheng Bio-technology Co., Ltd.

1 Qindongmen Street Haizhou Development Zone

130103, Lianyungang

address Changsheng Bio-technology Co Ltd(002680)

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Biopharmaceuticals

	1st Jan change	Capi.
CHANGSHENG BIO-TECHNOLOGY CO LTD	0.00%	106M
CSL LIMITED	-3.89%	88.14B
SAMSUNG BIOLOGICS CO.,LTD.	+1.45%	40.51B
BIOGEN INC.	-15.16%	31.67B
UCB	+51.27%	24.62B
BIOMARIN PHARMACEUTICAL INC.	-14.27%	15.65B
INCYTE CORPORATION	-14.38%	12.07B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-7.87%	11.97B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-42.56%	11.61B
SWEDISH ORPHAN BIOVITRUM AB	+5.92%	8.81B

Biopharmaceuticals